About Celcuity (CELC)
Celcuity, Inc. is a clinical-stage biotechnology company. The Company is focused on discovering cancer sub-types molecular-based approaches through developing companion diagnostic tests (CDx) and therapeutic (Rx). The Company's product pipeline inclu... Read more
- USD13.60
- USD13.60
- USD12.48
- USD19.77
- 7.50%
- --
- 612.00
- 164.73k
- 475M
- 7.58
- -24.90%
Stock News
45 minutes ago
Centene’s Medicaid business and healthcare costs are a problem, and its stock plunges
MarketWatch
1 hour ago
Gen Z is grappling with global chaos—here's how they're coping with 'inheriting broken systems'
CNBC
2 hours ago
Unum America closes reinsurance transaction with Fortitude Re
Yahoo
4 hours ago
Lyft: Value Stock With Growth Dynamics
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
